Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia — a phase II study

1992 ◽  
Vol 34 (5) ◽  
pp. 337-342 ◽  
Author(s):  
S. H. Lim ◽  
A. C. Newland ◽  
S. Kelsey ◽  
A. Bell ◽  
E. Offerman ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Intravenous Infusion ◽  
Phase Ii Study ◽  
Interleukin 2 ◽  
High Dose ◽  
Continuous Intravenous Infusion ◽  
Recombinant Interleukin 2 ◽  
Acute Myeloid

Continuous intravenous infusion of high dose recombinant interleukin 2 for advanced lymphomas—A phase II study

1991 ◽  
Vol 15 (6) ◽  
pp. 435-440 ◽  
Author(s):  
Seah H. Lim ◽  
Colin P. Worman ◽  
Therese Callaghan ◽  
Andrew Jewell ◽  
Mark P. Smith ◽  
...  
Keyword(s):  
Phase Ii ◽  
Intravenous Infusion ◽  
Phase Ii Study ◽  
Interleukin 2 ◽  
High Dose ◽  
Continuous Intravenous Infusion ◽  
Recombinant Interleukin 2

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

2009 ◽  
Vol 33 (8) ◽  
pp. 1124-1126 ◽  
Author(s):  
Patrice Chevallier ◽  
Mathilde Hunault-Berger ◽  
Fabrice Larosa ◽  
Charles Dauriac ◽  
Richard Garand ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
High Dose ◽  
Acute Myeloid

Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study

2008 ◽  
Vol 77 (4) ◽  
pp. 491-496 ◽  
Author(s):  
Robert Foa ◽  
Giovanna Meloni ◽  
Silvia Tosti ◽  
Anna Novarino ◽  
Susanna Fenu ◽  
...  
Keyword(s):  
Pilot Study ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Interleukin 2 ◽  
Recombinant Interleukin 2 ◽  
Acute Myeloid

Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: A pilot study

1990 ◽  
Vol 14 (11-12) ◽  
pp. 967-973 ◽  
Author(s):  
Donald Macdonald ◽  
Yinzheng Jiang ◽  
Andrea A. Gordon ◽  
Premini Mahendra ◽  
Ralph Oskam ◽  
...  
Keyword(s):  
Pilot Study ◽  
Complete Remission ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Interleukin 2 ◽  
Recombinant Interleukin 2 ◽  
First Complete Remission ◽  
Acute Myeloid

scholarly journals A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

2020 ◽  
Vol 190 (3) ◽  
Author(s):  
Walter Fiedler ◽  
Joerg Chromik ◽  
Stefanie Amberg ◽  
Maxim Kebenko ◽  
Felicitas Thol ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document